go-v.orgdoi

New developments in the diagnosis and treatment of axial spondyloarthritis

Pedro Machado, Robert Landewé, Désirée M F M van der Heijde · Clinical Investigation · 2013

  • DOI 10.4155/cli.12.148
  • Publisher OMICS Publishing Group
  • Type article
  • Issued 2013

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Clinical Investigation · OMICS Publishing Group · article · 2013

Abstract

Spondyloarthritis (SpA) is an umbrella term for a group of diseases sharing genetic, molecular, immunological, clinical and imaging features. The last few years have witnessed a remarkable progress in the understanding of SpA. Notable advances include the recognition of MRI as a sensitive and specific tool for detecting axial inflammation and the recent development and validation of the Assessment of Spondyloarthritis International Society classification criteria for predominantly axial and predominantly peripheral SpA.

This approach has the advantage of better describing the disease, allowing earlier identification and treatment of the non-radiographic forms and potentially leading to improved outcomes. TNF α-blockers, which dramatically improve the clinical symptoms and signs of patients with ankylosing spondylitis, are now being tested in patients with non-radiographic axial SpA, with the first studies providing evidence that patients with the non-radiographic form of the disease also benefit from this...

Open the resolved locator · 10.4155/cli.12.148

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 04:32 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://doi.org/10.4155/cli.12.148
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.